These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12206011)

  • 1. [The protection of renal function in the ACEI treatment of renal hypertension].
    Zhou QL; Yang JH; Chen LP
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):385-7. PubMed ID: 12206011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the relationship between plasma endothelin nitric oxide concentration and renal hypertension and renal function].
    Zhou Q; Sun M; Zhou H
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):381-3. PubMed ID: 12080656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of angiotension II receptor antagonist on the level ET and NO in the patients with renal hypertension and protection of renal function].
    Zhou QL; Deng SL; Yang JH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):583-4. PubMed ID: 12536552
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelin-1 and nitric oxide in patients on chronic hemodialysis.
    Tomić M; Galesić K; Markota I
    Ren Fail; 2008; 30(9):836-42. PubMed ID: 18925520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endothelin-1 and nitric oxide in the pathogenesis of hypertension in diabetic patients.
    Tomić M; Galesić K; Morović-Vergles J; Romić Z; Mikulić I
    Coll Antropol; 2008 Mar; 32(1):93-8. PubMed ID: 18496905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of blood pressure and endothelin-1 plasma concentration in young, hypertensive patients after treatment with angiotensin converting enzyme inhibitor].
    Bryl W; Miczke A; Bogdański P; Kujawska-Luczak M; Cymerys M; Pupek-Musialik D; Trojnarska O
    Pol Merkur Lekarski; 2005 May; 18(107):524-6. PubMed ID: 16161947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
    Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.
    Baylis C; Atzpodien EA; Freshour G; Engels K
    J Pharmacol Exp Ther; 2003 Dec; 307(3):854-60. PubMed ID: 14560039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of ACE-inhibitor on endothelin concentration and some metabolic parameters in young hypertensives].
    Bryl W; Pupek-Musialik D
    Pol Merkur Lekarski; 2006 Aug; 21(122):174-5; discussion 176. PubMed ID: 17144105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis.
    Ondocin PT; Narsipur SS
    Nephrology (Carlton); 2006 Dec; 11(6):497-501. PubMed ID: 17199786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal allograft protection with early angiotensin-converting enzyme inhibitors administration.
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    Transplant Proc; 2004 Apr; 36(3):692-4. PubMed ID: 15110633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
    Ardissino G; Viganò S; Testa S; Daccò V; Paglialonga F; Leoni A; Belingheri M; Avolio L; Ciofani A; Claris-Appiani A; Cusi D; Edefonti A; Ammenti A; Cecconi M; Fede C; Ghio L; La Manna A; Maringhini S; Papalia T; Pela I; Pisanello L; Ratsch IM;
    Nephrol Dial Transplant; 2007 Sep; 22(9):2525-30. PubMed ID: 17526542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].
    Zhang J; Chen BY; Han JY; Cao J; Guo MN; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):437-41. PubMed ID: 17673017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.